GCH1 and dopa-responsive dystonia: Targeted testing for GCH1, phenylalanine loading test, and repeat CSF neurotransmitter study ruled‐out GTP cyclohydrolase 1‐deficient dopa‐responsive dystonia (Segawa's disease).